Annual Revenue Comparison: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.

Pharma Revenue Trends: Bausch vs. Taro (2014-2023)

__timestampBausch Health Companies Inc.Taro Pharmaceutical Industries Ltd.
Wednesday, January 1, 20148263500000759285000
Thursday, January 1, 201510498800000862944000
Friday, January 1, 20169674000000950751000
Sunday, January 1, 20178724000000879387000
Monday, January 1, 20188380000000661913000
Tuesday, January 1, 20198601000000669893000
Wednesday, January 1, 20208027000000644769000
Friday, January 1, 20218434000000548970000
Saturday, January 1, 20228124000000561347000
Sunday, January 1, 20238757000000572952000
Monday, January 1, 2024629182000
Loading chart...

Unleashing the power of data

A Tale of Two Pharmaceutical Giants: Revenue Trends from 2014 to 2023

In the competitive landscape of pharmaceuticals, Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd. have showcased distinct revenue trajectories over the past decade. Bausch Health, with its robust portfolio, saw its revenue peak in 2015, reaching approximately 20% higher than its 2014 figures. However, the subsequent years witnessed a gradual decline, with 2020 marking a low point at around 8% below its 2015 peak. In contrast, Taro Pharmaceutical's revenue, though significantly smaller, displayed a more stable pattern, with a slight dip in 2021 but a promising recovery by 2023, showing a 4% increase from its 2021 figures. Notably, data for Bausch Health in 2024 is missing, leaving room for speculation on its future performance. This comparison highlights the dynamic nature of the pharmaceutical industry and the varying strategies companies employ to navigate market challenges.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025